Cryo-EM structure of transcription termination factor Rho from Mycobacterium tuberculosis reveals bicyclomycin resistance mechanism. 2022

Emmanuel Saridakis, and Rishi Vishwakarma, and Josephine Lai-Kee-Him, and Kevin Martin, and Isabelle Simon, and Martin Cohen-Gonsaud, and Franck Coste, and Patrick Bron, and Emmanuel Margeat, and Marc Boudvillain
Institute of Nanoscience and Nanotechnology, NCSR "Demokritos", Ag. Paraskevi, 15310, Athens, Greece.

The bacterial Rho factor is a ring-shaped motor triggering genome-wide transcription termination and R-loop dissociation. Rho is essential in many species, including in Mycobacterium tuberculosis where rho gene inactivation leads to rapid death. Yet, the M. tuberculosis Rho [MtbRho] factor displays poor NTPase and helicase activities, and resistance to the natural Rho inhibitor bicyclomycin [BCM] that remain unexplained. To address these issues, we solved the cryo-EM structure of MtbRho at 3.3 Å resolution. The MtbRho hexamer is poised into a pre-catalytic, open-ring state wherein specific contacts stabilize ATP in intersubunit ATPase pockets, thereby explaining the cofactor preference of MtbRho. We reveal a leucine-to-methionine substitution that creates a steric bulk in BCM binding cavities near the positions of ATP γ-phosphates, and confers resistance to BCM at the expense of motor efficiency. Our work contributes to explain the unusual features of MtbRho and provides a framework for future antibiotic development.

UI MeSH Term Description Entries
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D012234 Rho Factor A protein which effects termination of RNA synthesis during the genetic transcription process by dissociating the ternary transcription complex RNA;-RNA POLYMERASE DNA at the termination of a gene. E Coli Transcription Termination Factor,Factor, Rho
D014157 Transcription Factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process. Transcription Factor,Factor, Transcription,Factors, Transcription
D019086 Bridged Bicyclo Compounds, Heterocyclic Heterocyclic compounds that contain two rings that share two non-adjacent atoms in common. Bicyclo Compounds, Heterocyclic,Heterocyclic Cpds, Bicyclic,Bicyclic Heterocyclic Compounds,Heterocyclic Bicyclo Compounds,Bicyclic Heterocyclic Cpds,Heterocyclic Compounds, Bicyclic
D020285 Cryoelectron Microscopy Electron microscopy involving rapid freezing of the samples. The imaging of frozen-hydrated molecules and organelles permits the best possible resolution closest to the living state, free of chemical fixatives or stains. Electron Cryomicroscopy,Cryo-electron Microscopy,Cryo electron Microscopy,Cryo-electron Microscopies,Cryoelectron Microscopies,Cryomicroscopies, Electron,Cryomicroscopy, Electron,Electron Cryomicroscopies,Microscopies, Cryo-electron,Microscopies, Cryoelectron,Microscopy, Cryo-electron,Microscopy, Cryoelectron

Related Publications

Emmanuel Saridakis, and Rishi Vishwakarma, and Josephine Lai-Kee-Him, and Kevin Martin, and Isabelle Simon, and Martin Cohen-Gonsaud, and Franck Coste, and Patrick Bron, and Emmanuel Margeat, and Marc Boudvillain
January 2005, Structure (London, England : 1993),
Emmanuel Saridakis, and Rishi Vishwakarma, and Josephine Lai-Kee-Him, and Kevin Martin, and Isabelle Simon, and Martin Cohen-Gonsaud, and Franck Coste, and Patrick Bron, and Emmanuel Margeat, and Marc Boudvillain
January 2015, Methods in molecular biology (Clifton, N.J.),
Emmanuel Saridakis, and Rishi Vishwakarma, and Josephine Lai-Kee-Him, and Kevin Martin, and Isabelle Simon, and Martin Cohen-Gonsaud, and Franck Coste, and Patrick Bron, and Emmanuel Margeat, and Marc Boudvillain
July 2015, Nucleic acids research,
Emmanuel Saridakis, and Rishi Vishwakarma, and Josephine Lai-Kee-Him, and Kevin Martin, and Isabelle Simon, and Martin Cohen-Gonsaud, and Franck Coste, and Patrick Bron, and Emmanuel Margeat, and Marc Boudvillain
April 1993, Biochemistry,
Emmanuel Saridakis, and Rishi Vishwakarma, and Josephine Lai-Kee-Him, and Kevin Martin, and Isabelle Simon, and Martin Cohen-Gonsaud, and Franck Coste, and Patrick Bron, and Emmanuel Margeat, and Marc Boudvillain
October 2002, Biochemistry,
Emmanuel Saridakis, and Rishi Vishwakarma, and Josephine Lai-Kee-Him, and Kevin Martin, and Isabelle Simon, and Martin Cohen-Gonsaud, and Franck Coste, and Patrick Bron, and Emmanuel Margeat, and Marc Boudvillain
August 1995, Journal of bacteriology,
Emmanuel Saridakis, and Rishi Vishwakarma, and Josephine Lai-Kee-Him, and Kevin Martin, and Isabelle Simon, and Martin Cohen-Gonsaud, and Franck Coste, and Patrick Bron, and Emmanuel Margeat, and Marc Boudvillain
March 1998, Antimicrobial agents and chemotherapy,
Emmanuel Saridakis, and Rishi Vishwakarma, and Josephine Lai-Kee-Him, and Kevin Martin, and Isabelle Simon, and Martin Cohen-Gonsaud, and Franck Coste, and Patrick Bron, and Emmanuel Margeat, and Marc Boudvillain
March 2017, Nature communications,
Emmanuel Saridakis, and Rishi Vishwakarma, and Josephine Lai-Kee-Him, and Kevin Martin, and Isabelle Simon, and Martin Cohen-Gonsaud, and Franck Coste, and Patrick Bron, and Emmanuel Margeat, and Marc Boudvillain
August 2000, Biochemistry,
Emmanuel Saridakis, and Rishi Vishwakarma, and Josephine Lai-Kee-Him, and Kevin Martin, and Isabelle Simon, and Martin Cohen-Gonsaud, and Franck Coste, and Patrick Bron, and Emmanuel Margeat, and Marc Boudvillain
December 1998, The Journal of biological chemistry,
Copied contents to your clipboard!